Ambroxol Hydrochloride/Clenbuterol Hydrochloride

盐酸氨溴索/盐酸克仑特罗

Report date: 2022/04/20 10:12:40
NME

Base Information

Drug NameAmbroxol Hydrochloride/Clenbuterol Hydrochloride
Drug Alias Name氨溴特罗
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsSodium channel alpha subunitBeta-2 adrenergic receptor
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsRespiratory Tract Diseases
Approved Indications in ChinaRespiratory Tract Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date2004/03/17
Country/TerritoryMainland China
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRespiratory Tract Diseases
Inactive IndicationsN/A

Other Information

ATC CodeR03CC63
Related LinksN/A